Social and Economic Factors in the Choice of Lung Cancer Treatment

E. R. Greenberg, C. G. Chute, T. Stukel, J. A. Baron, D. H. Freeman, J. Yates, R. Korson

Research output: Contribution to journalArticlepeer-review

232 Scopus citations

Abstract

We reviewed 1808 hospital charts representing virtually all patients given a diagnosis of non-small-cell lung cancer in New Hampshire and Vermont between 1973 and 1976 and found that the treatment of patients varied according to their marital status, medical insurance coverage, and proximity to a cancer-treatment center. Patients were more likely to be treated with surgery if they were married (odds ratio, 1.67; 95 percent confidence interval, 1.08 to 2.57) or had private medical insurance (1.52; 1.03 to 2.26). Among patients who did not have surgery, those with private insurance were more likely to receive another form of anticancer therapy — either radiation or chemotherapy (1.57; 1.18 to 2.09). Residing farther from a cancer-treatment center was associated with a greater chance of having surgery. Patients 75 years of age and older were less likely to have surgery (0.16; 0.08 to 0.35) or any other tumor-directed therapy (0.32; 0.19 to 0.54). The relation between the type of treatment and a patient's characteristics was not based on apparent differences in tumor stage or functional status, although both these factors were also strongly predictive of the type of treatment. Despite the fact that privately insured and married patients were more aggressively treated, they did not survive longer after diagnosis. We conclude that for non-small-cell lung cancer, socioeconomic as well as medical factors determine treatment. (N Engl J Med 1988; 318:612–7.)

Original languageEnglish (US)
Pages (from-to)612-617
Number of pages6
JournalNew England Journal of Medicine
Volume318
Issue number10
DOIs
StatePublished - Mar 10 1988
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Social and Economic Factors in the Choice of Lung Cancer Treatment'. Together they form a unique fingerprint.

Cite this